|View printer-friendly version|
|Array BioPharma To Report Financial Results for the First Quarter of Fiscal 2003 On November 4, 2002|
|BOULDER, Colo., Oct 28, 2002 (BUSINESS WIRE) -- Array BioPharma Inc. (Nasdaq:
ARRY) will report financial results for the first quarter of fiscal 2003 on
Monday, November 4, 2002, at 4:30 p.m. eastern time and hold a conference call
on Tuesday, November 5, 2002, at 9:00 a.m. eastern time. Robert E. Conway, Chief
Executive Officer, and Michael Carruthers, Chief Financial Officer, will lead
CONFERENCE CALL INFORMATION
Date: Tuesday, November 5, 2002
Time: 9:00 a.m. eastern time
Toll-Free: (800) 967-7134
Toll: (719) 457-2625
Web Cast: www.arraybiopharma.com
There will be a replay of the conference call for one week, which can be accessed in the United States by dialing toll-free (888) 203-1112, and outside the United States (719) 457-0820. The access code is 146603. Replay of the call will also be available as a web cast on Array's web site at www.arraybiopharma.com.
Array BioPharma is a drug discovery company creating new small molecule drugs through the integration of chemistry, biology and informatics. Our experienced scientists use an integrated set of drug discovery technologies, which we call the Array Discovery Platform, to invent small molecule drugs in collaboration with leading pharmaceutical and biotechnology companies and to build our own pipeline of proprietary drug candidates. For more information on Array BioPharma, please visit our web site at www.arraybiopharma.com.
CONTACT: Array BioPharma Inc. Tricia Haugeto, 303/386-1193 firstname.lastname@example.org